|
M.S. Novikova, O.M. Koteshkova, M.B. Antsiferov
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
|
№4 / 2022
|
|
M.F. Kalashnikova, A.V. Zilov, D.R. Yazykova, N.V. Likhodey, V.V. Fadeev
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
|
№5 / 2016
|
|
G.R. Galstyan
HYPOGLYCEMIC EFFECTS OF FLOZINES COMPARED TO SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№17 / 2015
|
|
E.V.Surkova
EFFICACY AND SAFETY OF BIPHASIC INSULIN ANALOGUE NOVOMIX -30 IN TYPE 2 DIABETES MELLITUS: FROM CLINICAL RESEARCH TO REAL PRACTICE
|
№16 / 2014
|
|
V.I. Kudinov, M.S. Nichitenko, A.I. Chesnikova
THERAPY WITH LIRAGLUTIDE SIGNIFICANTLY IMPROVES GLYCEMIC CONTROL AND HAS POSITIVE IMPACT ON THE CARDIOVASCULAR SYSTEM OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
N.A. Chernikova 1, A.S. Ametov 1, M.B. Antsiferov 2
BASAL INSULIN THERAPY: EXPERIENCE IN CLINICAL PRACTICE
|
№16 / 2013
|
|
N. A. Chernikova, M.A. Prudnikova
Timely Administration Of Insulin Therapy In Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
Glinkina I.V., Romancova T.I.
Results Of Observational Program On Use Of Insulin Glargine (lantus®) In Combination With Oral Hypoglycemic Agents For The Treatment Of Type 2 Diabetes Mellitus In Routine Clinical Practice
|
№3 / 2011
|
|
Birukova E.V.
How To Achieve Effective Glycemic Control And Reduce The Risk Of Vascular Complications Due To Using Sulfonylurea Medications
|
№3 / 2011
|
|
Ye.V. Biryukova
Insulin Treatment Of Type 2 Diabetes Mellitus: A Choice And An Individual Approach
|
№16 / 2010
|
|
K.Sharafetdinov, O.Plotnikova С. 7378
Innovative Approaches To The Treatment Of Type 2 Diabetes Mellitus: The Role Of Specialized Product For Enteral Nutrition "glucerna Sr"
|
№3 / 2010
|
|
N.Petunina С. 3238
Advance – Movement Forward
|
№3 / 2010
|
Русский
